Vaginosis, Bacterial trials: Trial Insights

Filters: Condition: Vaginosis, Bacterial Clear all

232 trials match Source: ClinicalTrials.gov registrations

Trials started per year
Category	Trials
2002	2
2003	4
2004	3
2005	2
2006	5
2007	13
2008	6
2009	6
2010	10
2011	10
2012	7
2013	8
2014	15
2015	12
2016	13
2017	10
2018	4
2019	9
2020	14
2021	16
2022	12
2023	8
2024	18
2025	5
2026	16

Trials by status
Category	Trials
Completed	147
Unknown status	33
Recruiting	18
Terminated	14
Not yet recruiting	10
Withdrawn	5
Active, not recruiting	4
Enrolling by invitation	1

Top lead sponsors
Category	Trials
National Institute of Allergy and Infectious Diseases (NIAID)	8
Starpharma Pty Ltd	6
University of Pittsburgh	5
Gedea Biotech AB	4
Skaraborg Hospital	4
University of Alabama at Birmingham	4
Vaginal Biome Science	4
Guangdong Longchuangji Pharmaceutical Co., Ltd.	3
Hadassah Medical Organization	3
Peking University Shenzhen Hospital	3

Top conditions
Category	Trials
Vaginosis, Bacterial	232
Vaginitis	27
Candidiasis, Vulvovaginal	22
Premature Birth	14
Trichomonas Vaginitis	11
Candidiasis	10
Sexually Transmitted Diseases	10
Vaginal Diseases	10
Gonorrhea	7
Recurrence	7

Trials

Showing 76 to 100 of 232. Each trial links to its page on Pharma Observatory.

Efficacy and Safety of D005 Vaginal Mousse on Bacterial Vaginosis NCT04489290Not applicableUnknown statusPepTonic Medical ABStarted 2021
Evaluation of a Rapid Microscopic Diagnostic System for Different Vaginitis Conditions NCT04219605ObservationalCompletedMeir Medical CenterStarted 2020
Study of the Composition and Bacterial Diversity of the Vaginal Microbiota in Healthy Versus Pathological Conditions (Bacterial Vaginosis) Using a Targeted Metagenomic Approach (RNA 16s) NCT04989543Not applicableCompletedLarena SASStarted 2020
Pharmacokinetic Study of DARE-BV1 NCT05354050Phase 1CompletedDaré Bioscience, Inc.Started 2020
Effects of a Multi-strain Oral Probiotic on the Vaginal Microbiota Composition in Healthy Women and Women with Endometriosis NCT06592976Not applicableActive, not recruitingUniversity of Roma La SapienzaStarted 2020
Vaginal Microbiome Transplantation for Recurrent Bacterial Vaginosis NCT04517487Phase 1/2Active, not recruitingHadassah Medical OrganizationStarted 2020
Evaluation of Efficacy and Safety of Two New Formulations Compared to Gynomax® XL Ovule NCT06056947Phase 3CompletedEge UniversityStarted 2020
EFFICACY AND SAFETY OF OVA AND LAVAGE MEDICAL DEVICES IN THE TREATMENT OF NON-SPECIFIC VULVOVAGINITIS NCT05649735Not applicableCompletedOspedale del MareStarted 2020
DARE-BV1 in the Treatment of Bacterial Vaginosis (DARE-BVFREE) NCT04370548Phase 3CompletedDaré Bioscience, Inc.Started 2020
The Temporo-spatial Dynamics of Genital Tract Microbiota - an Observational Study in Oocyte Donors NCT04393857ObservationalCompletedPeter HumaidanStarted 2020
Effects of LiveSpo X-secret in Supporting Treatment of Sexually Transmitted Diseases NCT05783856Not applicableCompletedAnabio R&DStarted 2020
Effects of Video-based Health Education on Maternal and Child Health in Ethiopia NCT04414527Not applicableCompletedUniversity GhentStarted 2020
Point-of-care Tests for Bacterial Vaginosis and Candidosis NCT04287504ObservationalUnknown statusMedical University of ViennaStarted 2020
A Prospective, Randomized Controlled Study of the Probiotics as Adjuvant Treatment for Bacterial Vaginosis NCT04771728Phase 4RecruitingPeking University Shenzhen HospitalStarted 2020
Clinical Performance and Safety of the Gedea Pessary in Adult Women With Bacterial Vaginosis NCT04640922Not applicableCompletedGedea Biotech ABStarted 2020
The ASPIRE Trial - Aiming for Safe Pregnancies by Reducing Malaria and Infections of the Reproductive Tract NCT04189744Phase 3CompletedLondon School of Hygiene and Tropical MedicineStarted 2019
Estrogen, Probiotics and Vaginal Health to Prevent HIV Infection in ACB Women NCT03837015Phase 1CompletedMcMaster UniversityStarted 2019
Treatment of Bacterial Vaginosis Prior to Active Labor and Infectious Morbidity NCT03954990Phase 1TerminatedThe University of Texas Medical Branch, GalvestonStarted 2019
Suppression Of Bacterial Vaginosis (BV) [SUBVert] NCT03930745Phase 2CompletedNational Institute of Allergy and Infectious Diseases (NIAID)Started 2019
Postmenopausal Pessary Users: Estrogen Versus Trimosan NCT03943823Phase 4TerminatedThe University of Texas Health Science Center, HoustonStarted 2019
Evaluation of Efficacy and Safety of Gynomax® XL Ovule NCT03839875Phase 4CompletedExeltis TurkeyStarted 2019
Probiotics as Adjuvant Treatment for Bacterial Vaginosis NCT03894813Phase 4CompletedPeking University Shenzhen HospitalStarted 2019
Use of Vagitories Based on St. John's Wort, Tea Tree Oil and Shepherd's Purse in the Treatment of Vaginal Inflammation NCT04558697Phase 4CompletedUniversity of SarajevoStarted 2019
Clinical Performance of a Vaginal Pessary (pHyph) in Bacterial Vaginosis NCT03762083Not applicableCompletedGedea Biotech ABStarted 2019
Evaluate the Safety of a Single Oral Dose of Solosec™ (Secnidazole) 2g for the Treatment of Adolescent Girls With BV NCT03937869Phase 4CompletedLupin Research IncStarted 2018

132 more trials match. See them on Pharma Observatory

A Randomized, Multicenter, Open-label, Active-controlled Phase Ib Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of Multiple Intravaginal Doses of GenSci142 in Patients With Bacterial Vaginosis (BV) NCT07663838Status changeNot yet recruiting to RecruitingOctober 17, 2026
A Randomized, Multicenter, Open-label, Active-controlled Phase Ib Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of Multiple Intravaginal Doses of GenSci142 in Patients With Bacterial Vaginosis (BV) NCT07663838Enrollment change30 to 42October 17, 2026

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.

Visit Pharma Observatory